Skip to Main Content

Paper Details

Genome-wide analysis in 756,646 individuals provides first genetic evidence that <i>ACE2</i> expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease.
medRxiv
30
2021
ACE2, COVID-19, COVID-19 disease, SARS-CoV-2, angiotensin-converting enzyme 2, host cells, human, rare variant

Datasets

Release 1.2